New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
08:58 EDTANIKAnika announces dismissal of MONOVISC patent infringement suit
Anika Therapeutics announced that Genzyme and Anika filed a joint motion with the U.S. District Court for the District of Massachusetts to lift a stay and dismiss a patent infringement lawsuit concerning MONOVISC. MONOVISC received FDA PMA approval in February. The court granted the parties’ motion and issued an order dismissing the litigation with prejudice on March 10. This final and unappealable order resolves the parties’ dispute and is another important milestone toward commercialization of the product in the U.S.
News For ANIK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 10, 2014
17:32 EDTANIKAnika Therapeutics announces CMS assigned J-Code to MONOVISC, effective Jan. 1
Subscribe for More Information
November 9, 2014
20:15 EDTANIKAnika Therapeutics management to meet with Sidoti
Meeting to be held in Boston on November 13 hosted by Sidoti.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use